跳至主要内容
临床试验/JPRN-UMIN000013491
JPRN-UMIN000013491招募中2 期

Prospective Cohort Study Evaluating the Prognosis of Patients with Resectable Large 3 and 4 Type Gastric Cancer and Clinical Phase II trial Evaluating the Safety and Benefit of Perioperative Chemotherapy for Resectable Large 3 and 4 Type Gastric Cancer - CoBLa trial

Department of Surgical Oncology, Kanazawa Medical University0 个研究点目标入组 40 人开始时间: 2014年3月24日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. administration contraindication of TS-1, CDDP, DOC, PAC 2. severe complications such as paralytic ileus, bowel obstruction, interstitial pneumonitis or pulmonary fibrosis, uncontrolled diabetes mellitus, heart failure, renal failure and hepatic failure etc. 3. massive ascites or pleural effusion 4. severe watery diarrhea 5. schronous double cancer 6. pregnancy or lactation 7. physician concludes that the patient's participation in this trial is inappropriate

研究者

发起方
Department of Surgical Oncology, Kanazawa Medical University

相似试验